Viewing Opinion | StockChase
stockchase picture

Compiling comments that experts make about stocks while on public TV.

2017-04-20

Opinion for Johnson & Johnson (JNJ-N)

Signal Price Bias Subject Owned
TOP PICK $121.870 UNKNOWN DIVIDEND STOCKS AND MACRO STRATEGIES Yes

Recently missed on revenues and the stock sold off a bit. They actually beat on the earnings per share. This company has 3 solid lines of business, pharmaceuticals, consumer products and medical devices. There should be significant earnings growth this year. They did a significant acquisition last year which should be coming into earnings this year. Trading at about 20X earnings. Dividend yield of 2.6%. (Analysts’ price target is $130.)

Lorne Zeiler
Portfolio Manager & Wealth Advisor, TriDelta Financial

No Comments.


You must be logged in to comment.